January 27, 2015 8:34 PM ET

Pharmaceuticals

Company Overview of Acton Pharmaceuticals, Inc.

Company Overview

Acton Pharmaceuticals, Inc., a respiratory specialty pharmaceutical company, acquires, develops, and commercializes products to treat allergic, pulmonary, and other respiratory related diseases. Its AEROSPAN Inhalation Aerosol is an orally inhaled corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 6 years of age and older. The company was founded in 2008 and is headquartered in Marlborough, Massachusetts. As of October 21, 2013, Acton Pharmaceuticals, Inc. operates as a subsidiary of Meda AB.

225 Cedar Hill Street

Suite 337

Marlborough, MA 01752

United States

Founded in 2008

Phone:

508-624-8733

Key Executives for Acton Pharmaceuticals, Inc.

Co-Founder
Vice President of National Accounts and Managed Care
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Santaris Pharma A/S Corp United States
Tensha Therapeutics, Inc. United States
Taisho Pharmaceutical R&D Inc. United States
Jaguar Animal Health, Inc. United States
Aerovance, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Acton Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.